# Rahul R. Aggarwal, MD – FDA Inspection, Nov 21, 2017

Source: https://www.keypedia.com/records/fda_inspections/rahul-r-aggarwal-md/609e08eb-40b1-4374-a62a-205b31cb8cdc
Source feed: FDA_Inspections

> FDA inspection 1031837 of Rahul R. Aggarwal, MD, November 21, 2017. Classification: Voluntary Action Indicated (VAI). 1 citation under 21 CFR part 312. Form 483 issued.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1031837
- Company Name: Rahul R. Aggarwal, MD
- Inspection Date: 2017-11-21
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Bioresearch Monitoring
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 1

## Related Officers

- [Investigator](https://www.keypedia.com/people/joan-t-briones/f3b6554f-1a5c-4266-8a94-6c7488281659)
- [Company Rep](https://www.keypedia.com/people/thea-c-grome/ff1a4a19-f74c-485a-a177-f4cc5c5b7499)

Company: https://www.keypedia.com/companies/rahul-r-aggarwal-md/83e3a9b9-6342-489e-b7ef-aca2e40ab0bb

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c